Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Opioid Overdose (Trial 3 of 3)
Sponsor: State University of New York at Buffalo
Summary
The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will be randomized (within site) to either Remote (R) or In-Person (IP) Intake Groups. During the Intake, detailed consent and eligibility assessment will be completed. Participants who are eligible at the Intake will be randomized (within site and Intake Group) to R or IP Treatment and Assessment Groups. Participants will be followed for 3 months.
Official title: REMOTE VS. IN-PERSON STUDY EVALUATION (RISE) ABOVE OPIOID OVERDOSE
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-11
Completion Date
2028-05
Last Updated
2026-10-15
Healthy Volunteers
Yes
Interventions
Opioid Overdose Prevention Training
All participants receive a brief training video for the use of naloxone for opioid overdose prevention and a naloxone kit.
Locations (1)
University of Oklahoma Health Campus
Oklahoma City, Oklahoma, United States